Associate Medical Director
Alnylam Pharmaceuticals
Associate Medical Director
Alnylam Pharmaceuticals
Develops RNAi-based therapies for genetic diseases
Overview
Alnylam is the industry leader in the translation of RNA interference (RNAi) into a new class of innovative medicines with the potential to address the unmet needs of patients with debilitating diseases. Founded in 2002, Alnylam was built upon a bold vision of turning scientific possibility into reality and is now advancing a robust pipeline of investigational RNAi therapeutic medicines. Please visit www.alnylam.com for more information.
The Associate Medical Safety Director role is responsible for performing medical case review and providing medical expertise across individual case safety assessment, with emphasis on maintaining a consistent and harmonized medical review approach. This role will support ongoing review of safety data and aggregate datasets to identify emerging trends, patterns, inconsistencies, and potential safety signals, and will provide medical and clinical input into data review plans, safety surveillance activities, and safety monitoring strategies. The Associate Medical Safety Director will interface across all levels and functional areas of SRM and partner closely with Clinical Development, Data Management, Pharmacovigilance, and other cross-functional teams. The role will also support medical device safety assessment, including review and evaluation of device-related safety information and potential safety concerns.
Summary of Key Responsibilities
Qualifications
#LI-EW1 #LI-Remote
The pay range below reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on a number of factors including, but not limited to, relevant experience, skills, and education. This role is eligible for an annual short-term incentive award (e.g., bonus or sales incentive) and an annual long-term incentive award (e.g., equity).
Alnylam’s robust Total Rewards package is designed to support your overall health and well-being. We offer comprehensive benefits including medical, dental, and vision coverage, life and disability insurance, a lifestyle reimbursement program, flexible spending and health savings accounts and a 401(k)with a generous company match. Eligible employees enjoy paid time off, wellness days, holidays, and two company-wide recharge breaks. We also offer generous family resources and leave. Our commitment to your well-being reflects our belief that caring for our people fuels the impact we create together.
Learn more about these and additional benefits offered by Alnylam by visiting the Benefits section of the Careers website: https://www.alnylam.com/careers
U.S. Pay Range 192800 - 260800 USD
Develops RNAi-based therapies for genetic diseases
Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.
Explore more opportunities at Alnylam Pharmaceuticals